EGTON MEDICAL INFORMATION SYSTEMS LIMITED

• ◆

  3 officer resignations in last 12 months

  Multiple officers have left the board recently — see the People section for who.

Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Accounting basis

FRS 101

Reporting scope

Standalone (parent only)

Auditor

Grant Thornton UK LLP

Audit opinion

Unqualified (clean)

Going concern

Affirmed

“The Company is profitable and expects to continue to be so. It has significant cash resources, a high and continuing level of recurring revenue and also expects to continue to have high cash conversion for the foreseeable future. The Directors have performed a going concern assessment covering a period of at least twelve months from the date of approval of these financial statements. ... Consequently, given the strength of the financial performance and position of the Company, and the anticipated business outlook, the Directors are confident that the Company will have sufficient funds to continue to meet its liabilities as they fall due for at least a period of 12 months from the date of approval of these financial statements. The financial statements have therefore been prepared on a going concern basis.”

Group structure

1. EGTON MEDICAL INFORMATION SYSTEMS LIMITED · parent
   1. Proxemis Limited 50% · England & Wales · clinical trial solutions
   2. Footman-Walker Associates Limited 100% · England & Wales · dormant
   3. EMIS Health India Private Limited 10% · India · development of healthcare software
   4. ASC Computer Software (NZ) Limited 100% · New Zealand · dormant
   5. ASC Computer Software Pty. Ltd. 100% · Australia · dormant

Significant events

• “During the year exceptional costs of £5.9m (2023: £10.3m) were incurred in delivering a technology transformation programme as the Company transitions to the cloud. These included staff costs... third party costs... incremental depreciation and amortisation charges.”
• “A dividend of £48.9m was paid during the year (2023: £nil).”
• “As a result of the dividend for the year, shareholder's funds decreased by £21.3m to £49.1m (2023: £70.4m).”
• “During 2024 EMIS was recognised in 10 award ceremonies, including The Best Benefits Awards 2024, UK Company Culture Awards 2024 and the Employee Appreciation Awards 2024, highlighting our commitment to an excellent employee experience.”
• “On 15 April 2025, the company sold all its shares in Emis Health India Private Limited to another wholly owned subsidiary of the wider UnitedHealth Group for consideration of INR 191,031,700 (equivalent to approximately £1,685,772 using the exchange rate on the transaction date).”

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

Filings

8

last 12 months

Capital events

0

last 24 months

Officers appointed

3

last 12 months

Officers resigned

3

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.

• Turnover

  +1%

  £177,668,220 → £179,399,629

• Cash

  +252.5%

  £10,517,183 → £37,072,043

• Net assets

  -30.2%

  £70,444,291 → £49,145,076

• Employees

  +0.2%

  1,255 → 1,258

• Operating profit

  -11.5%

  £36,484,542 → £32,284,757

• Profit before tax

  -11.5%

  £36,947,520 → £32,697,308

• Wages

  -3.2%

  £72,361,243 → £70,072,161

Each % is (latest − prior) ÷ |prior| for the line item as filed. Periods don't have to be exactly 12 months apart — a long or short period (typical around incorporation or year-end changes) will distort the comparison. Lines a company doesn't report are omitted. About these numbers